A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients

Completed · Phase 2

Conditions studied: HIV Infections

In brief

This study will evaluate the drop in viral load over 10 days of treatment with S-1360 versus placebo in HIV-infected patients who have not previously taken anti-HIV medications.

Key facts

Study ID

NCT00046332

Run by

GlaxoSmithKline

People needed

100

Starts

2002-06-01

Expected to finish

2003-01-01

Last updated by the study team

2013-02-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• No prior HIV medications.
• HIV infection with viral load >400-50,000 copies/mL.
• CD4 cell count >50 cells/mm.

You may not qualify if…

• Patients requiring medications that cannot be interrupted for the duration of the study.
• Abnormal ECG or other chronic health conditions as noted on screening physical exam.
• Previous participation in an experimental drug trial(s) within 30 days of the screening visit for this study.

Where it is running

• GSK Clinical Trials Call Center — Phoenix, Arizona, United States
• GSK Clinical Trials Call Center — Los Angeles, California, United States
• GSK Clinical Trials Call Center — San Diego, California, United States
• GSK Clinical Trials Call Center — San Francisco, California, United States
• GSK Clinical Trials Call Center — West Hollywood, California, United States
• GSK Clinical Trials Call Center — Denver, Colorado, United States
• GSK Clinical Trials Call Center — Washington D.C., District of Columbia, United States
• GSK Clinical Trials Call Center — Altamonte Springs, Florida, United States
• GSK Clinical Trials Call Center — Fort Lauderdale, Florida, United States
• GSK Clinical Trials Call Center — Miami, Florida, United States
• GSK Clinical Trials Call Center — Tampa, Florida, United States
• GSK Clinical Trials Call Center — Atlanta, Georgia, United States
• GSK Clinical Trials Call Center — Indianapolis, Indiana, United States
• GSK Clinical Trials Call Center — Minneapolis, Minnesota, United States
• GSK Clinical Trials Call Center — New York, New York, United States
• GSK Clinical Trials Call Center — New York, New York, United States
• GSK Clinical Trials Call Center — New York, New York, United States
• GSK Clinical Trials Call Center — The Bronx, New York, United States
• GSK Clinical Trials Call Center — Chapel Hill, North Carolina, United States
• GSK Clinical Trials Call Center — Charlotte, North Carolina, United States
• GSK Clinical Trials Call Center — Durham, North Carolina, United States
• GSK Clinical Trials Call Center — Dallas, Texas, United States
• GSK Clinical Trials Call Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.